METHYLPREDNISOLONE COMPARED TO DEXAMETHASONE FOR THE TREATMENT OF HOSPITALIZED COVID-19 PATIENTS

被引：0
|
作者：
Kim, Sarah [1 ]
Cho, Nam [1 ]
Tellez, Eglis [2 ]
Moussavi, Kayvan [2 ,3 ]
机构：
[1] Loma Linda Univ, Med Ctr, Loma Linda, CA 92350 USA
[2] Marshall B Ketchum Univ, Coll Pharm, Fullerton, CA USA
[3] Marshall B Ketchum Univ, Providence St Joseph Orange, Providence, RI USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
795
引用
收藏
页码：388 / 388
页数：1
相关论文
共 50 条
  • [41] The Effect of Dexamethasone Treatment on COVID-19 Prognosis in Cancer Patients
    Souan, Lina
    Al-Khairy, Zienab
    Al-Binni, Maysaa' Adnan
    Battah, Abdelkader
    Sughayer, Maher A.
    VACCINES, 2022, 10 (11)
  • [42] Pulse Methylprednisolone Versus Dexamethasone in COVID-19: A Multicenter Cohort Study
    Watanabe, Atsuyuki
    Inokuchi, Ryota
    Kuno, Toshiki
    Uda, Kazuaki
    Komiyama, Jun
    Adomi, Motohiko
    Ishisaka, Yoshiko
    Abe, Toshikazu
    Tamiya, Nanako
    Iwagami, Masao
    CRITICAL CARE EXPLORATIONS, 2023, 5 (04) : E0886
  • [43] PULSE METHYLPREDNISOLONE VERSUS DEXAMETHASONE IN COVID-19: A MULTICENTER COHORT STUDY
    Watanabe, Atsuyuki
    Inokuchi, Ryota
    Kuno, Toshiki
    Uda, Kazuaki
    Komiyama, Jun
    Adomi, Motohiko
    Ishisaka, Yoshiko
    Abe, Toshikazu
    Tamiya, Nanako
    Iwagami, Masao
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 3 - 3
  • [44] Methylprednisolone or dexamethasone, which one is superior corticosteroid in the treatment of hospitalized COVID-19 patients: a triple-blinded randomized controlled trial (vol 21, 337, 2021)
    Ranjbar, Keivan
    Moghadami, Mohsen
    Mirahmadizadeh, Alireza
    Fallahi, Mohammad Javad
    Khaloo, Vahid
    Shahriarirad, Reza
    Erfani, Amirhossein
    Khodamoradi, Zohre
    Saadi, Mohammad Hasan Gholampoor
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [45] Efficacy of Dexamethasone and Methylprednisolone in COVID-19 Pneumonia Patients in Kolkata, India: A Retrospective Cohort Study
    Bhattacharjee, Boudhayan
    Ray, Indranil
    Ghosh, Sumit Kumar
    Talukdar, Arunansu
    Ghosh, Udas Chandra
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2024, 18 (07) : OC5 - OC11
  • [46] Baricitinib or Tocilizumab? Treatment of Patients Hospitalized With Severe COVID-19
    Cawcutt, Kelly A.
    Kalil, Andre C.
    CRITICAL CARE MEDICINE, 2023, 51 (03) : 413 - 415
  • [47] Janus Kinase inhibitors for the treatment of hospitalized patients with COVID-19
    Florescu, Diana F.
    Kalil, Andre C.
    CURRENT OPINION IN CRITICAL CARE, 2021, 27 (05) : 493 - 496
  • [48] QUICK REVIEW OF CURRENT COVID-19 TREATMENT IN HOSPITALIZED PATIENTS
    Bonifaz Diaz, Diego Raul
    Olivo Torres, Rosita Elizabeth del Carmen
    Lopez Dominguez, Delia Marlene
    Ramirez Lopez, Lotty Rosita
    REVISTA UNIVERSIDAD Y SOCIEDAD, 2021, 13 (06): : 590 - 597
  • [49] Edoxaban for the treatment of pulmonary embolism in hospitalized COVID-19 patients
    Langella, Valerio
    Bottino, Roberta
    Asti, Antonio
    Maresca, Giulio
    Di Palma, Gisella
    Pomponi, Domenico
    Sassone, Claudia
    Imbalzano, Egidio
    Russo, Vincenzo
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (10) : 1289 - 1294
  • [50] Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19
    Rosenberg, Eli S.
    Holtgrave, David R.
    Udo, Tomoko
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2020, 99 : 38 - 39
12345